Published in J Lab Clin Med on August 01, 1979
Anticardiolipin antibodies--clinical associations. Postgrad Med J (1986) 1.71
Antiphospholipid syndrome: five year follow up. Ann Rheum Dis (1991) 1.11
Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer. Br J Cancer (2011) 0.99
Coagulation abnormalities and cerebral infarction. J Neurol Neurosurg Psychiatry (1993) 0.98
Plasma von Willebrand factor in connective tissue disease. Ann Rheum Dis (1987) 0.91
The kidneys of mice with autoimmune disease acquire a hypofibrinolytic/procoagulant state that correlates with the development of glomerulonephritis and tissue microthrombosis. Am J Pathol (1997) 0.89
Indications of vascular endothelial cell dysfunction in systemic lupus erythematosus. Ann Rheum Dis (1987) 0.85
Fetal loss treatment in patients with antiphospholipid antibodies. Ann Rheum Dis (1989) 0.83
Methods for detecting lupus anticoagulants and their relation to thrombosis and miscarriage in patients with systemic lupus erythematosus. J Clin Pathol (1992) 0.81
Disseminated intravascular coagulation with renal and liver damage as the predominant manifestations of recurrent relapses in systemic juvenile rheumatoid arthritis. Ann Rheum Dis (1992) 0.80
Superior mesenteric artery thrombosis associated with antiphospholipid syndrome. West J Med (1991) 0.78
High frequency of spontaneous acute myocardial infarction due to small coronary artery disease in dead (NZWxBXSB)F1 male mice. Am J Pathol (1989) 0.78
Relation between antithrombin III and clinical and serological parameters in systemic lupus erythematosus. J Clin Pathol (1983) 0.77
Haemostatic factors associated with vascular thrombosis in patients with systemic lupus erythematosus and the lupus anticoagulant. Ann Rheum Dis (1991) 0.75
Lupus anticoagulant (LA) in pregnant women with history of recurrent fetal loss. J Blood Med (2011) 0.75
Postpartum spontaneous colonic perforation due to antiphospholipid syndrome. World J Gastroenterol (2009) 0.75
The antiphospholipid antibody dilemma. Clin Rheumatol (1990) 0.75
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood (1995) 16.81
Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med (1974) 6.77
Bleeding in renal failure: a possible cause. Br Med J (1976) 2.82
Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin. Lancet (1984) 2.47
Dexamethasone treatment for bacterial meningitis in children and adults. Pediatr Infect Dis J (1989) 2.37
Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients. AIDS (1996) 2.28
HIV infection with seroconversion after a superficial needlestick injury to the finger. N Engl J Med (1986) 1.73
Factor VIII gene inversions in severe hemophilia A: results of an international consortium study. Blood (1995) 1.59
Bernard-Soulier syndrome: a new platelet glycoprotein abnormality. Its relationship with platelet adhesion to subendothelium and with the factor VIII von Willebrand protein. J Lab Clin Med (1976) 1.58
Impaired anti-pneumococcal antibody response in patients with AIDS-related persistent generalized lymphadenopathy. Clin Exp Immunol (1987) 1.56
Splenectomy is safe and effective in human immunodeficiency virus-related immune thrombocytopenia. Blood (1993) 1.55
Tuberculosis meningitis, Abbassia Fever Hospital-Naval Medical Research Unit No. 3-Cairo, Egypt, from 1976 to 1996. Am J Trop Med Hyg (1998) 1.52
Recovery from anti-VIII:C (antihemophilic factor) autoimmune disease is dependent on generation of antiidiotypes against anti-VIII:C autoantibodies. Proc Natl Acad Sci U S A (1987) 1.49
CD8 lymphocytosis and pseudotumoral splenomegaly in HIV infection. Lancet (1992) 1.42
Platelet aggregation induced by type IIb platelet von Willebrand factor. Br J Haematol (1989) 1.42
Use of dexamethasone in treatment of enteric fever complicated by cerebellar involvement. Trans R Soc Trop Med Hyg (1994) 1.39
Cryptococcus neoformans antibody levels in patients with AIDS. Scand J Infect Dis (1988) 1.39
Report of the Working Party on Acquired Inhibitors of Coagulation: studies of the "lupus" anticoagulant. Thromb Haemost (1983) 1.34
Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance. Antimicrob Agents Chemother (1999) 1.33
Infection frequency of dendritic cells and CD4+ T lymphocytes in spleens of human immunodeficiency virus-positive patients. J Virol (1995) 1.32
Lymphoid interstitial pneumonitis in acquired immunodeficiency syndrome-related complex. Am Rev Respir Dis (1985) 1.32
Serum immunoglobulin G subclass dysbalances in the lymphadenopathy syndrome and acquired immune deficiency syndrome. Clin Exp Immunol (1986) 1.28
[Cardiac complications observed during treatment with rubidomycin]. Pathol Biol (1967) 1.27
[The "paraproteins" of types Ig G and Ig A in subjects without Kahler's disease]. Rev Fr Etud Clin Biol (1967) 1.24
Association of Mycoplasma penetrans with human immunodeficiency virus infection. J Infect Dis (1995) 1.20
Epidemiological survey of the orthopaedic status of severe haemophilia A and B patients in France. The French Study Group. secretariat.haemophiles@cch.ap-hop-paris.fr. Haemophilia (2000) 1.18
Haemophagocytic syndrome associated with plasmodium vivax infection. Br J Haematol (2000) 1.17
Von Willebrand's disease: combined qualitative and quantitative abnormalities. N Engl J Med (1977) 1.14
Multicenter retrospective study on the utilization of FEIBA in France in patients with factor VIII and factor IX inhibitors. French FEIBA Study Group. Factor Eight Bypassing Activity. Thromb Haemost (1997) 1.12
Waldenström's macroglobulinemia and peripheral neuropathy: a clinical and immunologic study of 25 patients. Blood (1983) 1.11
Hairy-cell leukaemia with polyarteritis nodosa. Lancet (1979) 1.09
In vitro correction of the abnormal multimeric structure of von Willebrand factor in type IIa von Willebrand's disease. Proc Natl Acad Sci U S A (1985) 1.08
Dexamethasone adjunctive treatment for tuberculous meningitis. Pediatr Infect Dis J (1991) 1.08
Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children. Clin Infect Dis (2000) 1.08
Allergic granulomatous vasculitis (Churg-Strauss Syndrome). Report of a case with widespread digestive involvement. Dig Dis Sci (1981) 1.07
Molecular analysis of clonality in Castleman's disease. Blood (1995) 1.04
Detection of heterozygotes in both parents of homozygous patients with Von Willebrand's disease. J Clin Pathol (1975) 1.04
Anti-idiotypes against autoantibodies and alloantibodies to VIII:C (anti-haemophilic factor) are present in therapeutic polyspecific normal immunoglobulins. Clin Exp Immunol (1988) 1.03
Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease. J Clin Invest (1975) 1.03
Sicca complex and infection with human immunodeficiency virus. Arch Intern Med (1987) 1.03
Short course chemotherapy with cefixime in children with multidrug-resistant Salmonella typhi Septicaemia. J Trop Pediatr (1995) 1.02
Carbohydrate deficiency of the factor VIII/von Willebrand factor Protein in von Willebrand's disease variants. Science (1976) 1.01
Natural antibodies to factor VIII (anti-hemophilic factor) in healthy individuals. Proc Natl Acad Sci U S A (1992) 1.01
Impaired T-lymphocyte-dependent immune responses to microbial antigens in patients with HIV-1-associated persistent generalized lymphadenopathy. AIDS (1988) 1.00
Up-regulation of adhesion and MHC molecules on splenic monocyte/macrophages in adult haemophagocytic syndrome. Br J Haematol (1999) 0.97
Complete remission of a primary effusion lymphoma with antiretroviral therapy. Am J Hematol (1998) 0.97
Antinuclear autoantibodies specific for lamins. Characterization and clinical significance. Ann Intern Med (1988) 0.97
[Intra-osseus hemorrhagic lesions in congenital afibrinogenemia. A new case (author's transl)]. J Radiol (1981) 0.96
Comparison of the efficacy, safety and cost of cefixime, ceftriaxone and aztreonam in the treatment of multidrug-resistant Salmonella typhi septicemia in children. Pediatr Infect Dis J (1995) 0.96
Catalytic activity of antibodies against factor VIII in patients with hemophilia A. Nat Med (1999) 0.96
Peripheral neuropathy and plasma cell neoplasias: a report of 10 cases. Br J Haematol (1981) 0.96
Immunoglobulin D-bearing lymphocytes in primary immunodeficiencies. J Immunol (1975) 0.96
Hepatitis C virus and Sjögren's syndrome. Arthritis Rheum (1993) 0.95
HIV type 1-specific IgG2 antibodies: markers of helper T cell type 1 response and prognostic marker of long-term nonprogression. AIDS Res Hum Retroviruses (2001) 0.95
Isolation and antibiotic susceptibility of Salmonella, Shigella, and Campylobacter from acute enteric infections in Egypt. J Health Popul Nutr (2000) 0.95
Primary pulmonary hypertension, tissue plasminogen activator antibodies, and HLA-DQ7. Am J Respir Crit Care Med (1997) 0.94
Toxoplasma gondii pneumonia in patients with the acquired immunodeficiency syndrome. Am J Med (1990) 0.94
Surface IgD in immunoproliferative disorders. Scand J Immunol (1974) 0.94
Transient angiolymphoid hyperplasia and Kaposi's sarcoma after primary infection with human herpesvirus 8 in a patient with human immunodeficiency virus infection. N Engl J Med (1998) 0.94
Zidovudine for thrombocytopenic purpura related to human immunodeficiency virus (HIV) infection. Ann Intern Med (1989) 0.94
Identification of the Rochalimaea henselae 16S rRNA sequence in the liver of a French patient with bacillary peliosis hepatis. J Infect Dis (1992) 0.94
Productive human immunodeficiency virus infection levels correlate with AIDS-related manifestations in the patient. Proc Natl Acad Sci U S A (1990) 0.93
[Epidemiology of infection by LAV/HTLV-III virus in hemophiliacs multitransfused in France. Results of a survey conducted by 28 hemophilia centers]. Nouv Rev Fr Hematol (1986) 0.93
Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor. J Clin Invest (1985) 0.93
Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease. J Lab Clin Med (1976) 0.92
AIDS-associated Kaposi's sarcoma in female patients. AIDS (1991) 0.92
Identification and cellular localization of plasminogen activators from human glomeruli. Thromb Haemost (1985) 0.92
Meningitis and encephalitis at the Abbassia Fever Hospital, Cairo, Egypt, from 1966 to 1989. Am J Trop Med Hyg (1993) 0.91
Congenital bleeding disorders with long bleeding time and normal platelet count. II. Von Willebrand's disease (report of thirty-seven patients). Am J Med (1968) 0.91
Platelet von Willebrand factor: an important determinant of the bleeding time in type I von Willebrand's disease. Blood (1986) 0.90
Clinical and pathologic features of Waldenström's macroglobulinemia in seven patients with serum monoclonal IgG or IgA. Am J Med (1977) 0.90
Glomerular lesions in monoclonal gammopathies and mixed essential cryoglobulinemias IgG-IgM. Adv Nephrol Necker Hosp (1971) 0.90
Low infection frequency of macrophages in the spleens of HIV+ patients. Res Virol (1997) 0.90
Matrix metalloproteinase-10 effectively reduces infarct size in experimental stroke by enhancing fibrinolysis via a thrombin-activatable fibrinolysis inhibitor-mediated mechanism. Circulation (2011) 0.89
Castleman disease in POEMS syndrome with elevated interleukin-6. Cancer (1993) 0.89
Localization of factor VIII/von Willebrand factor antigen by immunoelectron microscopy in human endothelial cells using Fab fragments coupled to peroxidase. J Histochem Cytochem (1982) 0.89
Acute sporadic hepatitis E in an Egyptian pediatric population. Am J Trop Med Hyg (1993) 0.88
Response to therapy in 37 patients with HIV-related thrombocytopenic purpura. Br J Haematol (1987) 0.88
Von Willebrand disease as an endothelial-cell abnormality. Lancet (1975) 0.88
Bacillary angiomatosis in HIV-infected patients: report of three cases with different clinical courses and identification of Rochalimaea quintana as the aetiological agent. Br J Dermatol (1995) 0.87
Platelet dysfunction in preleukemic states and in various types of leukemia. Ann N Y Acad Sci (1972) 0.87
Cefixime in the treatment of enteric fever in children. Drugs Exp Clin Res (1993) 0.87
A spectrophotometric solid-phase fibrin-tissue plasminogen activator activity assay (SOFIA-tPA) for high-fibrin-affinity tissue plasminogen activators. Anal Biochem (1986) 0.87
Chlorambucil-associated pneumonitis. Chest (1994) 0.87
Platelet factor VIII-related antigen: studies in vivo after transfusion in patients with von Willebrand disease. Blood (1978) 0.86
Spontaneous recurrent fetal wastage and autoimmune abnormalities: a study of fourteen cases. Clin Immunol Immunopathol (1986) 0.86
Enhanced plasminogen-activator production by leukocytes in the human and murine Chediak-Higashi syndrome. Blood (1985) 0.86
Fibrinolysis abnormalities in systemic lupus erythematosus and their relation to vasculitis. J Lab Clin Med (1988) 0.86
Progression to AIDS in French haemophiliacs: association with HLA-B35. AIDS (1993) 0.86
Abnormal platelet function, population, and survival-time in a boy with congenital absent radii and thrombocytopenia. Lancet (1972) 0.86
Azithromycin compared with rifampin for eradication of nasopharyngeal colonization by Neisseria meningitidis. Pediatr Infect Dis J (1998) 0.86
[Monoclonal immunoglobulins found in the absence of myeloma or Waldenström's macroglobulinemia. Evolution in 54 cases]. Nouv Rev Fr Hematol (1972) 0.85
[Refractory anemia with excess myeloblasts in the bone marrow. Study of 11 cases]. Presse Med (1970) 0.85
Origin of anti-idiotypic activity against anti-factor VIII autoantibodies in pools of normal human immunoglobulin G (IVIg). Blood (1992) 0.84
Treatment of the acquired immune deficiency syndrome-related Kaposi's sarcoma with bleomycin as a single agent. Cancer (1990) 0.84
[Ultrastructural abnormalities of erythroblasts and erythrocytes in 6 cases of congenital dyserythropoietic anemia]. Nouv Rev Fr Hematol (1973) 0.84